|
Volumn 121, Issue 10, 2014, Pages 2073-2074
|
Intravitreal therapy in bilateral neovascular age-related macular degeneration
a,b a c d e a a,f g h i a |
Author keywords
[No Author keywords available]
|
Indexed keywords
VASCULOTROPIN INHIBITOR;
ANGIOGENESIS INHIBITOR;
MONOCLONAL ANTIBODY;
RANIBIZUMAB;
AGE RELATED MACULAR DEGENERATION;
CHOROID;
CLINICAL PRACTICE;
COHORT ANALYSIS;
DRUG EFFICACY;
ENVIRONMENTAL FACTOR;
EYE;
EYE INJURY;
FOLLOW UP;
HUMAN;
NEOVASCULAR AGE RELATED MACULAR DEGENERATION;
RETINA NEOVASCULARIZATION;
RISK FACTOR;
SHORT SURVEY;
TREATMENT DURATION;
TREATMENT OUTCOME;
VISION;
VISUAL ACUITY;
AGED;
ARTICLE;
FEMALE;
INTRAVITREAL DRUG ADMINISTRATION;
MALE;
NEOVASCULARIZATION (PATHOLOGY);
RETINA MACULA DEGENERATION;
SUBRETINAL NEOVASCULARIZATION;
VERY ELDERLY;
AGED;
AGED, 80 AND OVER;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL, HUMANIZED;
CHOROIDAL NEOVASCULARIZATION;
COHORT STUDIES;
FEMALE;
HUMANS;
INTRAVITREAL INJECTIONS;
MACULAR DEGENERATION;
MALE;
NEOVASCULARIZATION, PATHOLOGIC;
VISUAL ACUITY;
|
EID: 84908122906
PISSN: 01616420
EISSN: 15494713
Source Type: Journal
DOI: 10.1016/j.ophtha.2014.05.007 Document Type: Article |
Times cited : (12)
|
References (5)
|